2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

Regular price€50,00
/
Tax included. Shipping calculated at checkout.

  • Free Shipping on orders over 45$
  • In stock, ready to ship
  • Inventory on the way

[

2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

Educational Objectives :

At the completion of this CME teaching activity, you should be able to:

  •  Discuss the challenges radiologists face when caring for a pediatric patient.
  • Differentiate serous, endometrial and sex cord tumors of the gynecologic track.
  •  Discuss the challenges associated with cervical lesions of the uterus.
  •  Achieve a better understanding of practical placental pathology.
  •  Identify inflammatory and reactive lesions of the breast.
  •  Achieve a greater understanding of problematic issues in breast core needle biopsies.
  •  Analyze post-neoadjuvant breast specimens.
  •  Identify spindle cell and vascular tumors of the breast.
  •  Discuss the recent updates to the ER/PR and HER2 testing guidelines.
  •  Apply molecular testing in the management of breast cancer.
  •  Achieve a better understanding of mesenchymal tumors of the uterus.
  •  Review problematic in situ lesions of the breast.
  • Achieve a better understanding of the challenges associated with melanocytic lesions in the pediatric population.
  •  Discuss the continuing dilemma of ductal carcinoma in situ.
  •  Review pseudolymphomas.

Program :

Serous Neoplasia of the Ovary
Mara H. Rendi, M.D., Ph.D.

Endometrial Neoplasia, Subtypes, Mimics and Molecular Testing
Mara H. Rendi, M.D., Ph.D.

Sex Cord Stromal Tumors of the Gynecologic Track
Mara H. Rendi, M.D., Ph.D.

Problematic Issues in Breast Core Needle Biopsies
Stuart J. Schnitt, M.D.

Inflammatory and Reactive Lesions of the Breast
Stuart J. Schnitt, M.D.

Evaluation of the Post-Neoadjuvant Chemotherapy Breast Specimen
Stuart J. Schnitt, M.D.

The Spectrum of Triple Negative Breast Cancer
Stuart J. Schnitt, M.D.

Pseudolymphomas
Alejandro Ariel Gru, M.D.

Update in Cutaneous Lymphomas in the WHO Classification
Alejandro Ariel Gru, M.D.

Superficial Mesenchymal Tumors in the Pediatric Setting
Alejandro Ariel Gru, M.D.

Cutaneous Histiocytic Neoplasms
Alejandro Ariel Gru, M.D.

The Challenging Melanocytic Lesions in the Pediatric Population
Alejandro Ariel Gru, M.D.

Challenging Cervical Lesions of the Uterus
Mara H. Rendi, M.D., Ph.D.

Mesenchymal Tumors of the Uterus
Mara H. Rendi, M.D., Ph.D.

Practical Placental Pathology
Mara H. Rendi, M.D., Ph.D.

Problematic In Situ Lesions of the Breast
Stuart J. Schnitt, M.D.

Spindle Cell and Vascular Lesions of the Breast
Stuart J. Schnitt, M.D.

The Continuing Dilemma of Ductal Carcinoma in Situ
Stuart J. Schnitt, M.D.

Molecular Testing & ER/PR, HER2 Guidelines in the Management of Patients with Breast Cancer
Stuart J. Schnitt, M.D.

]

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Testimonials

★★★★★


“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain
★★★★★


”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia
★★★★★

Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.

I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.

Richard Dorge
Winnipeg, MB

Recently viewed